Suppr超能文献

早期乳腺癌长期随访的肿瘤免疫微环境预测因素

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

作者信息

Okabe Mina, Toh Uhi, Iwakuma Nobutaka, Saku Shuko, Akashi Momoko, Kimitsuki Yuko, Seki Naoko, Kawahara Akihiko, Ogo Etsuyo, Itoh Kyogo, Akagi Yoshito

机构信息

Department of Surgery, Kurume University School of Medicine, Kurume, Japan.

Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, Japan.

出版信息

Cancer Sci. 2017 Jan;108(1):81-90. doi: 10.1111/cas.13114. Epub 2017 Jan 21.

Abstract

The aim of this research was to investigate the correlation of immunologic factors in the tumor environment of breast cancer, using immunohistological staining to evaluate the expression of programmed death 1/programmed death ligand 1 (PD-1/PD-L1), phosphatase and tensin homolog (PTEN), tumor infiltrating lymphocytes (TILs), and macrophages, and to analyze the association between the immunologic factors and clinical outcome for patients with early stage breast cancer (EBC). A total of 97 EBC patients who underwent standard surgery were investigated. Expression of PD-1/PD-L1 and PTEN and the density of CD3 TILs, CD8 TILs, and CD163 macrophages were evaluated by immunohistochemical analysis. The association between the immunologic factors and clinical outcome was statistically analyzed. The density of CD3 TILs, CD8 TILs, and CD163 macrophages and non-expression of PTEN was significantly higher in cases of triple negative breast cancer. CD8 TIL density and CD8 /PD-L1 expression were predictive factors for disease-free survival and overall survival (OS). Human epidermal growth factor 2 (HER2)-positive patients with PTEN expression and luminal/HER2-negative patients without PD-L1 expression had significantly longer OS compared to patients without PTEN expression (P = 0.049) and with PD-L1 expression (P = 0.036), respectively. Furthermore, patients with PD-L1 /CD8 expression had worse median progression-free survival (P = 0.022) and median OS (P = 0.037) compared with patients without PD-L1 /CD8 expression. The CD3 TILs, CD8 TILs, and CD163 macrophages were shown to infiltrate the tumor area of EBC. In particular, triple negative breast cancer had a higher rate of TIL infiltration within the tumor environment. Expression of PTEN and lack of PD-L1 expression were associated with favorable survival in HER2-positive and luminal/HER2-negative EBC patients, respectively. The PD-L1 expression combined with CD8 density was significantly associated with an aggressive clinical outcome.

摘要

本研究旨在探讨乳腺癌肿瘤环境中免疫因素的相关性,采用免疫组织化学染色评估程序性死亡1/程序性死亡配体1(PD-1/PD-L1)、磷酸酶和张力蛋白同源物(PTEN)、肿瘤浸润淋巴细胞(TILs)和巨噬细胞的表达,并分析这些免疫因素与早期乳腺癌(EBC)患者临床结局之间的关联。共调查了97例行标准手术的EBC患者。通过免疫组织化学分析评估PD-1/PD-L1和PTEN的表达以及CD3 TILs、CD8 TILs和CD163巨噬细胞的密度。对免疫因素与临床结局之间的关联进行统计学分析。三阴性乳腺癌患者中CD3 TILs、CD8 TILs和CD163巨噬细胞的密度以及PTEN的不表达显著更高。CD8 TIL密度和CD8/PD-L1表达是无病生存期和总生存期(OS)的预测因素。与无PTEN表达(P = 0.049)和有PD-L1表达(P = 0.036)的患者相比,人表皮生长因子2(HER2)阳性且有PTEN表达的患者以及腔面/HER2阴性且无PD-L1表达的患者的OS显著更长。此外,与无PD-L1/CD8表达的患者相比,有PD-L1/CD8表达的患者的中位无进展生存期(P = 0.022)和中位OS(P = 0.037)更差。CD3 TILs、CD8 TILs和CD163巨噬细胞被证实浸润EBC的肿瘤区域。特别是,三阴性乳腺癌在肿瘤环境中的TIL浸润率更高。PTEN的表达和PD-L1表达的缺乏分别与HER2阳性和腔面/HER2阴性EBC患者的良好生存相关。PD-L1表达与CD8密度相结合与侵袭性临床结局显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa1/5276839/eac8cd896110/CAS-108-81-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验